HEADER HYDROLASE/HYDROLASE INHIBITOR 03-NOV-11 3UHM TITLE UDP-3-O-[3-HYDROXYMYRISTOYL] N-ACETYLGLUCOSAMINE DEACETYLASE IN TITLE 2 COMPLEX WITH INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: UDP-3-O-[3-HYDROXYMYRISTOYL] N-ACETYLGLUCOSAMINE COMPND 3 DEACETYLASE; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: PROTEIN ENVA, UDP-3-O-ACYL-GLCNAC DEACETYLASE; COMPND 6 EC: 3.5.1.-; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PSEUDOMONAS AERUGINOSA; SOURCE 3 ORGANISM_TAXID: 287; SOURCE 4 GENE: LPXC, ENVA, PA4406; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET21B KEYWDS AMIDOHYDROLASES, ANTI-BACTERIAL AGENTS, BACTERIA, CATALYTIC DOMAIN, KEYWDS 2 DRUG DESIGN, ENZYME INHIBITORS, GRAM NEGATIVE, HYDROLASE-HYDROLASE KEYWDS 3 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.MONTGOMERY,S.LIU REVDAT 3 13-SEP-23 3UHM 1 REMARK SEQADV LINK REVDAT 2 02-JAN-13 3UHM 1 JRNL REVDAT 1 01-FEB-12 3UHM 0 JRNL AUTH J.I.MONTGOMERY,M.F.BROWN,U.REILLY,L.M.PRICE,J.A.ABRAMITE, JRNL AUTH 2 J.ARCARI,R.BARHAM,Y.CHE,J.M.CHEN,S.W.CHUNG,E.M.COLLANTES, JRNL AUTH 3 C.DESBONNET,M.DOROSKI,J.DOTY,J.J.ENGTRAKUL,T.M.HARRIS, JRNL AUTH 4 M.HUBAND,J.D.KNAFELS,K.L.LEACH,S.LIU,A.MARFAT,L.MCALLISTER, JRNL AUTH 5 E.MCELROY,C.A.MENARD,M.MITTON-FRY,L.MULLINS,M.C.NOE, JRNL AUTH 6 J.O'DONNELL,R.OLIVER,J.PENZIEN,M.PLUMMER,V.SHANMUGASUNDARAM, JRNL AUTH 7 C.THOMA,A.P.TOMARAS,D.P.UCCELLO,A.VAZ,D.G.WISHKA JRNL TITL PYRIDONE METHYLSULFONE HYDROXAMATE LPXC INHIBITORS FOR THE JRNL TITL 2 TREATMENT OF SERIOUS GRAM-NEGATIVE INFECTIONS. JRNL REF J.MED.CHEM. V. 55 1662 2012 JRNL REFN ISSN 0022-2623 JRNL PMID 22257165 JRNL DOI 10.1021/JM2014875 REMARK 2 REMARK 2 RESOLUTION. 1.26 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.26 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 12.70 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 66.9 REMARK 3 NUMBER OF REFLECTIONS : 48435 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.181 REMARK 3 R VALUE (WORKING SET) : 0.180 REMARK 3 FREE R VALUE : 0.201 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.040 REMARK 3 FREE R VALUE TEST SET COUNT : 2441 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.26 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.29 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 66.87 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 284 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1988 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 272 REMARK 3 BIN R VALUE (WORKING SET) : 0.1932 REMARK 3 BIN FREE R VALUE : 0.3391 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.23 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 12 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2334 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 34 REMARK 3 SOLVENT ATOMS : 242 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 9.37 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 15.21 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.17560 REMARK 3 B22 (A**2) : -0.86080 REMARK 3 B33 (A**2) : 2.03640 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.81940 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.166 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.068 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.922 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.914 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2418 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3268 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 859 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 63 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 360 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2418 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 0 ; 5.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 312 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3095 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.10 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 4.61 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 13.28 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|1 - A|303 } REMARK 3 ORIGIN FOR THE GROUP (A): 1.3124 0.0605 6.9198 REMARK 3 T TENSOR REMARK 3 T11: 0.0051 T22: 0.0087 REMARK 3 T33: 0.0044 T12: 0.0051 REMARK 3 T13: -0.0004 T23: -0.0036 REMARK 3 L TENSOR REMARK 3 L11: 0.2472 L22: 0.3767 REMARK 3 L33: 0.2108 L12: 0.0131 REMARK 3 L13: -0.0189 L23: 0.0467 REMARK 3 S TENSOR REMARK 3 S11: 0.0068 S12: -0.0156 S13: -0.0033 REMARK 3 S21: -0.0083 S22: 0.0016 S23: -0.0077 REMARK 3 S31: 0.0131 S32: 0.0113 S33: -0.0084 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3UHM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-NOV-11. REMARK 100 THE DEPOSITION ID IS D_1000068765. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 48477 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.260 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 66.7 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.04600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.26 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.31 REMARK 200 COMPLETENESS FOR SHELL (%) : 73.0 REMARK 200 DATA REDUNDANCY IN SHELL : 1.70 REMARK 200 R MERGE FOR SHELL (I) : 0.08700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 7.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 2VES REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.46 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 40.48250 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 441 O HOH A 494 1.98 REMARK 500 O HOH A 410 O HOH A 521 2.04 REMARK 500 O THR A 61 O HOH A 447 2.17 REMARK 500 O HOH A 444 O HOH A 447 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 60 44.96 -141.09 REMARK 500 MET A 103 -126.00 59.60 REMARK 500 SER A 106 -169.18 -118.88 REMARK 500 ASP A 218 -156.50 -91.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 300 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 78 NE2 REMARK 620 2 HIS A 237 NE2 95.4 REMARK 620 3 ASP A 241 OD1 97.0 98.6 REMARK 620 4 ASP A 241 OD2 149.0 90.2 52.1 REMARK 620 5 RFN A 303 O4 125.4 90.5 135.6 84.8 REMARK 620 6 RFN A 303 O5 91.3 165.5 93.4 90.6 75.2 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RFN A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GAI A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 302 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3U1Y RELATED DB: PDB DBREF 3UHM A 1 299 UNP P47205 LPXC_PSEAE 1 299 SEQADV 3UHM SER A 40 UNP P47205 CYS 40 ENGINEERED MUTATION SEQRES 1 A 299 MET ILE LYS GLN ARG THR LEU LYS ASN ILE ILE ARG ALA SEQRES 2 A 299 THR GLY VAL GLY LEU HIS SER GLY GLU LYS VAL TYR LEU SEQRES 3 A 299 THR LEU LYS PRO ALA PRO VAL ASP THR GLY ILE VAL PHE SEQRES 4 A 299 SER ARG THR ASP LEU ASP PRO VAL VAL GLU ILE PRO ALA SEQRES 5 A 299 ARG ALA GLU ASN VAL GLY GLU THR THR MET SER THR THR SEQRES 6 A 299 LEU VAL LYS GLY ASP VAL LYS VAL ASP THR VAL GLU HIS SEQRES 7 A 299 LEU LEU SER ALA MET ALA GLY LEU GLY ILE ASP ASN ALA SEQRES 8 A 299 TYR VAL GLU LEU SER ALA SER GLU VAL PRO ILE MET ASP SEQRES 9 A 299 GLY SER ALA GLY PRO PHE VAL PHE LEU ILE GLN SER ALA SEQRES 10 A 299 GLY LEU GLN GLU GLN GLU ALA ALA LYS LYS PHE ILE ARG SEQRES 11 A 299 ILE LYS ARG GLU VAL SER VAL GLU GLU GLY ASP LYS ARG SEQRES 12 A 299 ALA VAL PHE VAL PRO PHE ASP GLY PHE LYS VAL SER PHE SEQRES 13 A 299 GLU ILE ASP PHE ASP HIS PRO VAL PHE ARG GLY ARG THR SEQRES 14 A 299 GLN GLN ALA SER VAL ASP PHE SER SER THR SER PHE VAL SEQRES 15 A 299 LYS GLU VAL SER ARG ALA ARG THR PHE GLY PHE MET ARG SEQRES 16 A 299 ASP ILE GLU TYR LEU ARG SER GLN ASN LEU ALA LEU GLY SEQRES 17 A 299 GLY SER VAL GLU ASN ALA ILE VAL VAL ASP GLU ASN ARG SEQRES 18 A 299 VAL LEU ASN GLU ASP GLY LEU ARG TYR GLU ASP GLU PHE SEQRES 19 A 299 VAL LYS HIS LYS ILE LEU ASP ALA ILE GLY ASP LEU TYR SEQRES 20 A 299 LEU LEU GLY ASN SER LEU ILE GLY GLU PHE ARG GLY PHE SEQRES 21 A 299 LYS SER GLY HIS ALA LEU ASN ASN GLN LEU LEU ARG THR SEQRES 22 A 299 LEU ILE ALA ASP LYS ASP ALA TRP GLU VAL VAL THR PHE SEQRES 23 A 299 GLU ASP ALA ARG THR ALA PRO ILE SER TYR MET ARG PRO HET ZN A 300 1 HET RFN A 303 25 HET GAI A 301 4 HET EDO A 302 4 HETNAM ZN ZINC ION HETNAM RFN (2R)-N-HYDROXY-2-METHYL-2-(METHYLSULFONYL)-4-(2-OXO-4- HETNAM 2 RFN PHENYLPYRIDIN-1(2H)-YL)BUTANAMIDE HETNAM GAI GUANIDINE HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 2 ZN ZN 2+ FORMUL 3 RFN C17 H20 N2 O5 S FORMUL 4 GAI C H5 N3 FORMUL 5 EDO C2 H6 O2 FORMUL 6 HOH *242(H2 O) HELIX 1 1 ARG A 53 GLU A 55 5 3 HELIX 2 2 VAL A 76 LEU A 86 1 11 HELIX 3 3 ALA A 107 GLY A 118 1 12 HELIX 4 4 HIS A 162 ARG A 166 5 5 HELIX 5 5 SER A 177 VAL A 185 1 9 HELIX 6 6 ASP A 196 ASN A 204 1 9 HELIX 7 7 ASP A 232 LEU A 248 1 17 HELIX 8 8 GLY A 263 ASP A 277 1 15 HELIX 9 9 ASP A 288 ALA A 292 5 5 SHEET 1 A 2 LYS A 3 LEU A 7 0 SHEET 2 A 2 LEU A 119 ALA A 125 -1 O GLN A 122 N GLN A 4 SHEET 1 B 5 ILE A 11 VAL A 16 0 SHEET 2 B 5 LYS A 23 LYS A 29 -1 O LEU A 28 N ILE A 11 SHEET 3 B 5 ALA A 91 LEU A 95 -1 O GLU A 94 N THR A 27 SHEET 4 B 5 ILE A 37 ARG A 41 1 N VAL A 38 O VAL A 93 SHEET 5 B 5 VAL A 48 PRO A 51 -1 O VAL A 48 N ARG A 41 SHEET 1 C 3 VAL A 57 GLU A 59 0 SHEET 2 C 3 THR A 65 LYS A 68 -1 O THR A 65 N GLU A 59 SHEET 3 C 3 VAL A 71 VAL A 73 -1 O VAL A 73 N LEU A 66 SHEET 1 D 5 VAL A 135 GLU A 139 0 SHEET 2 D 5 LYS A 142 VAL A 147 -1 O PHE A 146 N VAL A 135 SHEET 3 D 5 SER A 252 PHE A 260 -1 O PHE A 260 N ARG A 143 SHEET 4 D 5 PHE A 152 ILE A 158 1 N SER A 155 O PHE A 257 SHEET 5 D 5 GLN A 170 ASP A 175 -1 O GLN A 170 N ILE A 158 SHEET 1 E 5 VAL A 135 GLU A 139 0 SHEET 2 E 5 LYS A 142 VAL A 147 -1 O PHE A 146 N VAL A 135 SHEET 3 E 5 SER A 252 PHE A 260 -1 O PHE A 260 N ARG A 143 SHEET 4 E 5 PHE A 128 ILE A 131 1 N ILE A 129 O SER A 252 SHEET 5 E 5 TRP A 281 VAL A 284 -1 O VAL A 284 N PHE A 128 SHEET 1 F 2 PHE A 191 PHE A 193 0 SHEET 2 F 2 ILE A 215 VAL A 217 1 O ILE A 215 N GLY A 192 LINK NE2 HIS A 78 ZN ZN A 300 1555 1555 2.08 LINK NE2 HIS A 237 ZN ZN A 300 1555 1555 2.06 LINK OD1 ASP A 241 ZN ZN A 300 1555 1555 2.03 LINK OD2 ASP A 241 ZN ZN A 300 1555 1555 2.68 LINK ZN ZN A 300 O4 RFN A 303 1555 1555 2.10 LINK ZN ZN A 300 O5 RFN A 303 1555 1555 2.11 CISPEP 1 ASP A 45 PRO A 46 0 3.80 SITE 1 AC1 4 HIS A 78 HIS A 237 ASP A 241 RFN A 303 SITE 1 AC2 16 LEU A 18 HIS A 19 MET A 62 GLU A 77 SITE 2 AC2 16 HIS A 78 THR A 190 PHE A 191 GLY A 192 SITE 3 AC2 16 LEU A 200 HIS A 237 LYS A 238 ASP A 241 SITE 4 AC2 16 HIS A 264 ZN A 300 EDO A 302 HOH A 375 SITE 1 AC3 3 LEU A 205 ALA A 206 HOH A 470 SITE 1 AC4 6 MET A 62 PHE A 191 GLY A 192 PHE A 193 SITE 2 AC4 6 ASP A 196 RFN A 303 CRYST1 34.138 80.965 49.779 90.00 95.50 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.029293 0.000000 0.002821 0.00000 SCALE2 0.000000 0.012351 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020182 0.00000